A Shared Mission for Women

Sisters Maureen and Laurie are on a mission to transform women’s health—starting with menopause. With decades of combined experience in advanced nursing, holistic wellness, and education, they’ve joined forces to empower women to understand their bodies, advocate for their needs, and make informed decisions about their care. Through their work at Vitality Collective, they’re helping women connect the dots between symptoms, hormones, and solutions—offering education, support, and personalized guidance. Their shared passion is rooted in one belief: when women are informed, they are powerful. And it’s time we all had access to the knowledge and resources we deserve.

FDA Removes Black Box Warning on Estrogen Products

FDA Removes Black Box Warning on Estrogen Products

FDA Removes “Black Box” Warnings from Menopausal Hormone Therapy

A New Era for Women’s Health
The U.S. Food and Drug Administration (FDA) has officially begun removing the long-standing “Black Box” warnings from menopausal hormone replacement therapy (HRT) products — a major step toward restoring confidence in these life-changing treatments.

What This Means
Hormone therapy (HRT) — including estrogen and progesterone — is FDA-approved to relieve hot flashes, night sweats, vaginal dryness, and other symptoms of menopause. Some formulations are also approved to help prevent osteoporosis.

After reviewing decades of clinical data, the FDA determined that the previous warning language overstated certain risks and deterred women from receiving a beneficial therapy. Updated labeling will now reflect a more balanced and accurate understanding of HRT’s benefits and potential risks.

Key Updates

  • The FDA is removing boxed warnings related to cardiovascular disease, breast cancer, and dementia.

  • The only remaining boxed warning applies to women with an intact uterus using unopposed estrogen (without progesterone), which can increase the risk of endometrial cancer.

  • The FDA now recommends that systemic HRT be started within 10 years of menopause onset or before age 60, when benefits are greatest and risks lowest.

Evidence-Based Benefits
Research shows that women who initiate HRT early in menopause may experience:

  • Up to 50% lower heart attack risk

  • 64% lower risk of cognitive decline

  • 35% lower Alzheimer’s risk

  • Reduced all-cause mortality and fracture risk

Analyses of more than 30 major trials (over 26,000 women) show no increase in cancer mortality — and even a potential reduction for those starting therapy before age 60.

In Summary
The FDA’s decision marks a significant shift in women’s healthcare policy. By modernizing outdated warnings, the agency empowers women — in partnership with their providers — to make informed, individualized choices about hormone therapy for both symptom relief and long-term health.

The Safety of HRT

Is Menopausal Hormone Replacement Therapy

Dr. Deborah Matthew’s article, Is Menopausal Hormone Replacement Therapy Safe?, dispels myths about HRT risks. Starting estrogen therapy within 10 years of menopause or before 60 can lower heart disease, stroke, and mortality risks. Estrogen alone is not linked to higher breast cancer risk and may reduce it. She stresses the importance of hormone type, timing, and delivery, favoring bioidentical hormones and personalized plans. Essential for women considering menopause symptom management and HRT benefits and risks.

Is HRT Safe for Menopause? New Guidelines Say Yes

New guidelines from University Hospitals confirm hormone replacement therapy (HRT) is safe and effective for many women with menopause symptoms. Though a 2002 study raised concerns, later research shows starting HRT before 60 or within 10 years of menopause offers benefits like relief from hot flashes, mood swings, and protection against osteoporosis and heart disease. Individualized care and informed discussions with healthcare providers are essential for personalized treatment.

  • The Menopause Society (TMS)

    The Menopause Society (formerly the North American Menopause Society) is a leading authority on menopause and provides some of the most comprehensive guidance on MHT. Its 2022 position statement emphasizes an individualized approach to therapy based on a woman's health profile. 

    Key takeaways from the 2022 position statement:

    • MHT is considered the most effective treatment for hot flashes, genitourinary syndrome, and preventing bone loss.

    • Treatment decisions should be individualized, using the lowest effective dose for the shortest necessary duration.

    • Generally, benefits outweigh risks for healthy women under 60 or within 10 years of menopause who have bothersome symptoms.

    • MHT can be continued beyond age 65 for persistent symptoms or osteoporosis prevention after evaluating benefits and risks.

    • MHT is recommended for women with premature or early menopause until at least the average age of menopause, if there are no contraindications.

    • MHT is for managing menopausal symptoms, not for the primary prevention of chronic diseases. 

    • Blog Link for more Details

  • The Endocrine Society

    The Endocrine Society also supports MHT, stating in its guidelines that for many women, the benefits outweigh the risks. 

    Key takeaways from the 2015 and subsequent guidelines:

    • MHT is the most effective treatment for vasomotor and other climacteric symptoms.

    • For symptomatic postmenopausal women under age 60 or within 10 years of menopause, benefits may exceed risks.

    • MHT should not be used to prevent chronic diseases.

    • Transdermal estrogen is recommended for women at increased risk of blood clots.

    • Progestogen is needed for women with a uterus taking estrogen to prevent uterine cancer. 

  • American College of Obstetricians and Gynecologists (ACOG)

    ACOG guidelines support systemic hormone therapy as the most effective treatment for bothersome vasomotor symptoms. 

    Key takeaways:

    • Systemic MHT is recommended for managing vasomotor symptoms.

    • Topical hormonal therapies are preferred for vaginal symptoms due to fewer side effects.

    • ACOG recommends using the lowest effective dose for the shortest duration. 

    ACOG on Bioidentical / Compounded Hormone Therapy

    • In its “Compounded Bioidentical Menopausal Hormone Therapy” consensus (Nov 2023), ACOG says: FDA‐approved hormone therapies should be preferred over compounded bioidentical formulations when they are available. ACOG

    • Compounded bioidentical hormone therapies have less evidence regarding safety, efficacy, dosing consistency, potency, quality control, pharmacokinetics, etc. Many compounded products are not FDA-approved. ACOG

    • Patients should be counseled about these uncertainties and risks if considering compounded bioidentical HT. Shared decision-making is essential.

The Menopause Society Updates Hormone Therapy Guidance

For the first time since 2017, The Menopause Society (TMS) has released an updated position statement on hormone therapy, endorsed by more than 20 leading medical organizations worldwide.

The new guidance confirms that for healthy women under 60, and within 10 years of menopause onset, the benefits of hormone therapy outweigh the risks. Hormone therapy remains the most effective treatment for hot flashes, night sweats, and other vasomotor symptoms, while also improving sleep, mood, and quality of life. It can reduce osteoporosis risk and support genitourinary health with topical estrogen options.

Key points include:

  • FDA-approved uses: vasomotor symptoms, osteoporosis prevention, early menopause/POI, and vulvovaginal atrophy.

  • Broader benefits: better sleep, skin support, and lower risk of certain eye conditions.

  • Risks: increased when therapy starts after age 60 or more than 10 years after menopause onset, particularly with oral forms.

  • Cancer: Estrogen alone carries no increased breast cancer risk for the first 7 years; combined therapy may slightly raise risk after 4+ years.

  • Compounded hormones: not recommended due to lack of regulation and safety data.

TMS emphasizes the importance of individualized care, guided by a menopause-trained clinician, to weigh each woman’s unique risks and benefits.

If you are ready to explore whether Hormone Replacement Therapy is right for you. Book a no-obligation discovery call today.

Trusted Hormone Health Resources

Why We Share Trusted Resources

Hormone health can feel overwhelming, and not every source online is reliable. At Vitality Collective, we believe education is empowerment. That’s why we’ve curated a library of trusted, evidence-based resources—so you have clear information to guide conversations with your care team and make confident choices for your health.

Estrogen Matters

📚 Why Estrogen Matters – A Must-Read for Every Woman Exploring Hormone Health

If you've ever been told that estrogen is dangerous—or that hormone therapy is only a last resort—you’re not alone. In Estrogen Matters, oncologist Dr. Avrum Bluming and social scientist Dr. Carol Tavris set the record straight, challenging decades of misinformation surrounding estrogen and menopause.

This powerful, evidence-based book debunks the long-standing myths that have made millions of women afraid of hormone replacement therapy (HRT). With clarity, compassion, and scientific rigor, the authors explain how estrogen, far from being harmful, can actually protect against heart disease, bone loss, cognitive decline, and even certain cancers when used appropriately.

Whether you're navigating perimenopause, menopause, or simply exploring your options, Estrogen Matters is an essential read that empowers women with knowledge, not fear.

👉 We recommend this book as a trusted resource for women (and their providers!) who want to do their own research and make informed decisions about hormone health. At Vitality Collective Hormone Health, we believe in evidence-based care, individualized support, and advocating for what your body truly needs.

Thyroid Talk
Written by Dr. Angela Mazza
Published 2024

📚 The New Menopause – A Modern Guide to Thriving Through Midlife and Beyond

Hormones. Weight gain. Brain fog. Sleepless nights. If you’ve felt confused, dismissed, or unsupported during perimenopause or menopause, The New Menopause by Dr. Mary Claire Haver is the empowering, science-backed guide you’ve been waiting for.

Written by a board-certified OB-GYN and fierce advocate for women's health, this book cuts through outdated advice and gives women the real facts about what’s happening in their bodies. Dr. Haver dives into the latest research on hormone therapy, metabolic health, nutrition, mental wellness, and how to reclaim your power in midlife—with clarity and compassion.

Far from being a decline, menopause can be a powerful reset—if you have the right tools.

👉 We recommend The New Menopause for any woman seeking to understand her changing body, advocate for better care, and thrive during this transformational stage. At Vitality Collective Hormone Health, we support women with the education, insight, and personalized support they deserve.

📘 Thyroid Talk – An Integrative Guide to Understanding Your Thyroid

Fatigue. Weight changes. Hair thinning. Anxiety. Constipation. Brain fog.
If you’ve ever been told “your labs are normal” while still feeling anything but normal, Thyroid Talk by Dr. Angela Mazza may be the missing link you’ve been looking for.

Written by a board-certified endocrinologist with advanced training in integrative and functional medicine, this book bridges the gap between conventional thyroid care and a more comprehensive, root-cause approach. Dr. Mazza explains how thyroid physiology truly works—beyond just TSH—and explores the interconnected roles of free T4, free T3, reverse T3, antibodies, gut health, nutrient status, stress, and environmental influences.

Rather than viewing the thyroid in isolation, Thyroid Talk helps readers understand the full-body impact of thyroid dysfunction—from metabolism and cardiovascular health to mood, cognition, and hormonal balance. With clarity and practicality, Dr. Mazza empowers patients to ask better questions, interpret their labs more intelligently, and advocate for more personalized care.

Your thyroid is not just a number on a lab slip—it’s a master regulator of energy, metabolism, and vitality.

👉 We recommend Thyroid Talk for anyone navigating hypothyroidism, Hashimoto’s, persistent symptoms despite treatment, or simply wanting a deeper understanding of thyroid health. At Vitality Collective Hormone Health, we believe informed women make empowered decisions—and education is the first step toward restoring balance.

Vitality Collective Blogs

  • Why Your Cholesterol is Climbing in Midlife

    Why It’s Not Just About Your Diet

    If you’re a woman in your 40s or 50s and your cholesterol has suddenly spiked—even though nothing about your lifestyle has changed—you are not alone, and you are not broken.

  • Understanding Heart Palpitations During Menopause

    You’re Not Alone

    Heart palpitations during perimenopause and menopause can be unsettling, often causing your heart to race, flutter, or skip beats. These episodes are typically linked to hormonal fluctuations—especially declining estrogen levels.

  • The Power of Magnesium

    Why It Matters for Everyone (Especially Women in Menopause)

    Magnesium is one of the most essential minerals for human health — yet many people are chronically deficient without even realizing it. It plays a critical role in over 300 enzymatic processes in the body, including energy production, muscle function, brain health, and stress regulation.

  • Hormone Therapy After Age 65: What the New Research Really Says

    A new large-scale study published in Menopause, the journal of The Menopause Society, is helping clarify an important question many women ask: Is hormone therapy safe and effective after age 65?

    Hormone therapy (HT) remains one of the most effective treatments for hot flashes and other menopausal symptoms. Current guidelines have traditionally recommended starting therapy before age 60 or within 10 years of menopause onset. However, real-world experience shows that many women continue to have significant symptoms well beyond age 65 — and some begin therapy later.

    This new study followed more than 83,000 women over a 22-year period and examined health outcomes in those who started or continued hormone therapy after age 65.

  • L-Theanine: the “calm focus” amino acid

    If you’ve ever wanted to feel more relaxed without feeling dulled, L-theanine is one of the most-loved, most-studied options in the supplement world. It’s gentle, well tolerated for most people, and tends to support a very specific vibe: less mental “edge,” more steady clarity.

    And yes—there is research that has compared L-theanine to a benzodiazepine (the medication class that includes Xanax).

    L-theanine is an amino acid found naturally in tea leaves (especially green tea). It’s best known for supporting relaxation without heavy sedation—often described as a calm, steady, “I can still think” kind of support.

Free
Download

The Bioidentical Hormone Revolution by Donna White is a powerful, science-backed guide that dismantles decades of fear and misinformation surrounding hormone therapy. Perfect for both curious patients and forward-thinking providers, this book explains what bioidentical hormones are, how they work, and why they are safer and more effective than outdated synthetic options.

Readers will learn how to navigate perimenopause, menopause, and postmenopause with clarity, reclaiming energy, mental sharpness, libido, and long-term health. With insights from landmark 2024 studies, the book also addresses cancer risks, heart health, and cognitive decline—empowering women to advocate for personalized, evidence-based care.

Whether you’re seeking relief from symptoms or exploring clinical best practices, this eBook is your invitation to join the hormone health revolution—and finally feel like yourself again.

Free Hormone Health Email Series

Learn about hormone health and bioidentical hormones with our FREE email series.

Podcasts That Matter

  • The Hormone Solution with Karen Martel

    The Great Estrogen Debate with Dr. Felice Gersh, Dr. Daved Rosensweet, Dr. Lindsey Berkson, Dr. Julie Taguchi & Karen Martel

    In this must-listen episode, four of the top minds in hormone therapy—Dr. Felice Gersh, Dr. Daved Rosensweet, Dr. Lindsey Berkson, and Dr. Julie Taguchi—dive deep into the science and strategy behind effective hormone replacement therapy (HRT) for women.

    They explore the distinct roles of estrone, estradiol, and estriol, the debate between estradiol-only vs. combination approaches, and the importance of maintaining natural hormone rhythms. The conversation highlights emerging research on estrogen receptor beta agonists and their potential in cancer prevention, as well as the impact of inflammation, hormone dosing, and individualized protocols on long-term health outcomes.

    Whether you’re a practitioner or a woman seeking answers, this episode offers powerful insights into how personalized, well-informed HRT can support bone, brain, immune, and cardiovascular health—especially when paired with nutrition and lifestyle strategies.

  • The Drive Dr. Peter Attia

    Women’s sexual health, menopause, and hormone replacement therapy (HRT) | Rachel Rubin, M.D.

    Rachel Rubin is a board-certified urologist & one of the nation's foremost experts in sexual health. She shares her deep expertise on the topic of women’s sexual health, exploring why this area remains so neglected in traditional medicine & highlighting the critical differences in how men & women experience hormonal decline with age. Rachel explains the physiology of the menstrual cycle, the complex hormonal shifts of perimenopause, & the health risks associated with menopause, including osteoporosis, cardiovascular disease, dementia, & recurrent urinary tract infections. She discusses the controversy surrounding hormone replacement therapy (HRT) & provides guidance on the safe & personalized use of estrogen, progesterone, & testosterone in women. With particular emphasis on local vaginal hormone therapy—a safe, effective, & underused treatment—Rachel offers insights that have the potential to transform quality of life for countless women.

  • The Drive Dr. Peter Attia

    Avrum Bluming, M.D. and Carol Tavris, Ph.D.: A compelling case for hormone replacement therapy

    In this compelling episode, hematologist and oncologist Dr. Avrum Bluming joins forces with social psychologist and acclaimed author Carol Tavris to unpack their groundbreaking book, Estrogen Matters. Together, they tackle the long-standing confusion and fear surrounding hormone replacement therapy (HRT) for women in menopause. Drawing parallels between flawed dietary guidelines and the misunderstood science behind HRT, they present a clear, evidence-based argument that postmenopausal hormone therapy—when appropriately prescribed—offers significant benefits without increasing breast cancer risk. The episode explores the history and fallout of the Women’s Health Initiative, while also diving into the latest research on HRT's role in preventing cardiovascular disease, osteoporosis, and cognitive decline.

We’re Here to Help

At Vitality Collective, we offer a comprehensive, whole-body approach to midlife wellness that includes hormone testing, personalized bioidentical hormone replacement therapy (BHRT), metabolic support, wellness coaching, and concierge care. Whether you’re already on a statin, exploring GLP-1s, or just starting to ask questions, we’re ready when you are.

You are not crazy. This is real. And we can help.